Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 8 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
EMULCO LABORATORIES from Gent, company number BE0874567440, closed financial year 2025 with a result of € -319,899 after tax. For that financial year EMULCO LABORATORIES recorded a gross margin of € 107,165 and equity of € -119,459. Compared with financial year 2024, the result moved from € -404,356 to € -319,899. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ -119,459
▼ € 392,568 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -319,899
▲ 21 % less loss than in 2024
Profit after tax over the fiscal year.
€ 16,791
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3.1 million.
People and assets in 2025
1.8
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 182,091
▼ 11% vs 2024
€ 101,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 179,021
▲ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,603
▼ 55% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -90,202 | € -28,727 | € 39,163 | € 107,165 | ▲ 174% |
| Profit after taxes | € -554,097 | € -505,022 | € -404,356 | € -319,899 | ▲ € 84,457 |
| Equity | € -672,174 | € 750,135 | € 273,109 | € -119,459 | ▼ € 392,568 |
| Total debts | € 3,746,108 | € 2,173,493 | € 2,277,319 | € 2,582,536 | ▲ 13% |
| Cash | € 6,596 | € 4,529 | € 16,568 | € 16,791 | ▲ 1% |
| Retained profit | € -1,908,965 | € -2,413,987 | € -2,818,343 | € -3,138,242 | ▼ € 319,899 |
| Bank debt | € 9,080 | € 2,723 | € 0 | € 0 | |
| Balance sheet total | € 3,073,934 | € 2,923,627 | € 2,550,428 | € 2,463,077 | ▼ 3% |
| Employees (FTE) | 2 | 2 | 2 | 1.8 | ▼ 0.2 |
Key figures of EMULCO LABORATORIES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EMULCO LABORATORIES?
What happened at EMULCO LABORATORIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Whitestone Group NV stepped down as director. NBB
- CAP28 BV stepped down as director. NBB
- Bernard Goblet stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 319,899. filed late Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 554,097 loss in 2022 to € 319,899 loss in 2025.
Paid € 2,383 in corporate taxes since 2022.
On average € 59,500 of value added per employee in 2025.
Management
The stake of Emulco comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
EMULCO LABORATORIESThe shares are held by Emulco (100%).
Directors
According to the 2025 annual accounts
Director · represented by Antoine Duchateau
Also active at: ATIMA-TPIM, TILMAN, NEWTREE, ISO - TECH BELGIUM, Emulco, EMAsphere, TREESTONE, WHITESTONE PROPERTIES +7 more
· until 2028
· until 2028
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Henri Farmanstraat 25
9000 Gent
Henri Farmanstraat 25 box 535
9000 Gent
Active since 26 August 2005
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.567.440
- VAT number
- BE 0874.567.440
- Registered office
- Henri Farmanstraat 25, 9000 Gent
- Names & denominations
- EMULCO LABORATORIES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 June 2005
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in chemische producten voor industrieel gebruik
Groothandel in chemische producten
Handelsbemiddeling in de groothandel in brandstoffen, ertsen, metalen en chemische producten
Technische studiën en ingenieursactiviteiten
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts